Gewandter JS, et al. – In this present study, the authors evaluate the design characteristics and reporting quality of published randomized controlled trials (RCTs) for treatments of chemotherapy–induced peripheral neuropathy (CIPN) initiated before or during chemotherapy. These findings identify reporting practices that can be improved in order to enhance readers' ability to critically assess RCTs of CIPN treatments and use the findings to inform the design of future studies and clinical practice. Reporting instructions are provided.